Long-Term Data On Cimzia® (certolizumab Pegol) For Moderate To Severe Crohn's Disease To Be Highlighted At ACG Meeting
Links shared publicly online about this topic.
- 797total visits
Long-Term Data On Cimzia® (certolizumab Pegol) For Moderate To Severe Crohn's Disease To Be Highlighted At ACG Meeting
View full resource at medicalnewstoday.com
Tags: IBD, Crohn's Disease, Crohn's Disease Medication, Disease and Condition, Cimzia, disease, Education
Most Recently Shared on October 16, 2010 at 1:05 pm By:
Long-Term Data On Cimzia® (certolizumab Pegol) For Moderate To Severe Crohn's Disease To Be Highlighted At ACG Mee... http://mnt.to/3Lkm
Also Shared By:
Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets
newswise.com — “A new analysis concludes that rituximab, a drug commonly used to treat blood cancers, leads to treatment responses lasting at least five years in approximately one quarter of patients with low platelet counts and a risk of bleeding due to chronic immune thrombocytopenic purpura (ITP). In study results published online today in Blood, the Journal of the American Society of Hematology (ASH), investigators at Weill Cornell Medical College provide the very first long-term outcome data for patients w” View full resource at newswise.com
Most Recently Shared on May 7, 2012 at 4:44 pm By:
#health news: Rituximab Promotes Long-Term Response for Patients with Immune Destruction of Platelets http://t.co/ebFOkm4e
MedWire News - Lipidology - Total and HDL cholesterol associated with stroke risk
medwire-news.md — “MedWire News Long-term follow-up data from a cohort of Finnish men and women have shown an association between total and high-density lipoprotein cholesterol levels and stroke risk. MedWire News” View full resource at medwire-news.md
Most Recently Shared on April 14, 2012 at 9:08 pm By:
Total and HDL cholesterol associated with stroke risk: Long-term follow-up data from a cohort of Finnish men and... http://t.co/DlcGTmES
MedWire News - Stroke - Total and HDL cholesterol associated with stroke risk
medwire-news.md — “MedWire News Long-term follow-up data from a cohort of Finnish men and women have shown an association between total and high-density lipoprotein cholesterol levels and stroke risk. MedWire News” View full resource at medwire-news.md
Most Recently Shared on April 13, 2012 at 6:32 pm By:
Total and HDL cholesterol associated with stroke risk: Long-term follow-up data from a cohort of Finnish men and... http://t.co/8xx42PP3
Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies? | Vascular Disease Management
vasculardiseasemanagement.com — “Long-term results with bare-metal LifeStent in the SFA: Is this bad news for DES technologies? | Vascular Disease Management” View full resource at vasculardiseasemanagement.com
Most Recently Shared on April 13, 2012 at 4:40 pm By:
Vascular Disease Man Medical Journal
Dr. Criado's April blog explores 3-year follow-up data from the RESILIENT trial. http://t.co/3ZWOSmU2
Phase 3 Trial Update of Kynamro for Hypercholesterolemia - MPR
empr.com — “Genzyme and Isis Pharmaceuticals announced new two-year data from a phase 3 long-term extension study of Kynamro (mipomersen sodium) in patients with familial hypercholesterolemia (FH).” View full resource at empr.com
Most Recently Shared on March 29, 2012 at 2:32 pm By:
Phase 3 Trial Update of #Kynamro for #Hypercholesterolemia #cholesterol #cardiologist http://t.co/6QCwWJ65
Novel drug in pill form safer than standard approach to treat blocked lung blood vessels
medicalxpress.com — “A novel oral anti-coagulant outperformed the injected standard therapy on important safety measures for initial and long-term treatment of pulmonary embolism – a blockage of lung blood vessels usually caused by a clot – and showed comparable efficacy, according to data from the EINSTEIN-PE ...” View full resource at medicalxpress.com
Most Recently Shared on March 26, 2012 at 3:30 pm By:
PhysOrg Health News Health News
Novel drug in pill form safer than standard approach to treat blocked lung blood vessels http://t.co/tyxObO6R
MedWire News - Prostate Cancer - Latest PSA data supports screening
medwire-news.md — “MedWire News Screening men for prostate-specific antigen significantly reduces their long-term risk for death from prostate cancer, shows an updated analysis of the European Randomized Study of Screening for Prostate Cancer. MedWire News” View full resource at medwire-news.md
Most Recently Shared on March 24, 2012 at 5:36 am By:
Latest PSA data supports screening: Screening men for prostate-specific antigen significantly reduces their long... http://t.co/pZi8psRi
Long-Term ECG Monitoring System Offers Advanced Arrhythmia Analysis
medgadget.com — “Biomedical Systems (Maryland Heights, MO) has introduced an ambulatory ECG monitoring system that can record and wirelessly transmit heartbeat data for up” View full resource at medgadget.com
Most Recently Shared on March 22, 2012 at 6:03 pm By:
[News] Long-Term ECG Monitoring System Offers Advanced Arrhythmia Analysis http://t.co/l074stWy #medicaldevice
MedWire News - Oncology - Latest PSA data supports screening
medwire-news.md — “MedWire News Screening men for prostate-specific antigen significantly reduces their long-term risk for death from prostate cancer, shows an updated analysis of the European Randomized Study of Screening for Prostate Cancer. MedWire News” View full resource at medwire-news.md
Most Recently Shared on March 21, 2012 at 5:03 pm By:
Latest PSA data supports screening http://t.co/dHqzpwCC
News From The Annals Of Internal Medicine: March 20, 2012
medicalnewstoday.com — “1. Dapagliflozin Effective Add-on for Patients with Inadequately Controlled Blood GlucoseExperts caution that long-term safety data is still lacking Even on high doses” View full resource at medicalnewstoday.com
Most Recently Shared on March 20, 2012 at 10:05 am By:
News From The Annals Of Internal Medicine: March 20, 2012 http://t.co/3u91SfII #diabetes
theheart.org: trusted cardiology news and opinions
theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.” View full resource at theheart.org
Most Recently Shared on March 16, 2012 at 6:57 am By:
Statins linked with lower Parkinson's disease risk: Preliminary data hint that regular long-term use of choleste... http://t.co/YJ7Hf346
New data fuels debate over prostate cancer screening | Fox News
foxnews.com — “Updated results from a long-term study concludes that regular prostate cancer screening cuts the risk of death from prostate cancer” View full resource at foxnews.com
Most Recently Shared on March 15, 2012 at 12:44 pm By:
George Huba, Ph.D. Psychologist, PhD, and Doctor
FOX: New data fuels debate over prostate cancer screening - Updated results from a long-term study concludes that re... http://t.co/3S7bn4kW
New data fuels debate over prostate cancer screening | Fox News
foxnews.com — “Updated results from a long-term study concludes that regular prostate cancer screening cuts the risk of death from prostate cancer” View full resource at foxnews.com
Most Recently Shared on March 15, 2012 at 12:36 pm By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
New data fuels debate over prostate cancer screening: Updated results from a long-term study concludes that regu... http://t.co/CePzao8O
New data fuel debate over prostate cancer screening | Lifescript.com
lifescript.com — “NEW YORK (Reuters Health) - Updated results from a long-term study concludes that regular prostate...” View full resource at lifescript.com
Most Recently Shared on March 15, 2012 at 10:28 am By:
Health News: New data fuel debate over prostate cancer screening http://t.co/qHOtCoHt
New data fuel debate over prostate cancer screening | Lifescript.com
lifescript.com — “NEW YORK (Reuters Health) - Updated results from a long-term study concludes that regular prostate...” View full resource at lifescript.com
Most Recently Shared on March 15, 2012 at 9:58 am By:
New data fuel debate over prostate cancer screening http://t.co/8kfpGcDc
Advertisement
MNT Crohn's / IBD
@mnt_crohns
Long-Term Data On Cimzia® (certolizumab Pegol) For Moderate To Severe Crohn's Disease To Be Highlighted At ACG Mee... http://mnt.to/3Lkm
1 year ago...